Production (Stage)
Cartesian Therapeutics, Inc.
RNAC
$10.46
$0.13831.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 180.43M | 212.61M | 219.20M | 87.23M | 103.42M |
| Total Receivables | 1.77M | 872.00K | 5.81M | 35.51M | 4.38M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.92M | 3.14M | 4.13M | 2.04M | 3.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 300.00K |
| Total Current Assets | 185.12M | 216.63M | 229.14M | 124.78M | 111.11M |
|
|
|||||
| Total Current Assets | 185.12M | 216.63M | 229.14M | 124.78M | 111.11M |
| Net Property, Plant & Equipment | 15.53M | 15.45M | 23.75M | 20.52M | 11.96M |
| Long-term Investments | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Total Other Intangibles | 150.60M | 150.60M | 150.60M | 150.60M | 150.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.72M | 2.19M | 1.67M | 1.67M | 1.38M |
| Total Assets | 409.13M | 435.02M | 455.32M | 347.74M | 325.21M |
|
|
|||||
| Total Accounts Payable | 2.10M | 288.00K | 517.00K | 2.86M | 2.52M |
| Total Accrued Expenses | 8.67M | 11.29M | 9.02M | 7.74M | 8.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.70M | 2.85M | 2.77M | 2.52M | 2.23M |
| Total Finance Division Other Current Liabilities | 531.00K | 8.54M | 9.09M | 12.99M | 22.98M |
| Total Other Current Liabilities | 531.00K | 8.54M | 9.09M | 12.99M | 22.98M |
| Total Current Liabilities | 15.00M | 22.98M | 21.41M | 26.12M | 36.65M |
|
|
|||||
| Total Current Liabilities | 15.00M | 22.98M | 21.41M | 26.12M | 36.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.36M | 11.13M | 11.88M | 12.34M | 8.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 405.56M | 407.72M | 421.28M | 410.74M | 397.13M |
| Total Liabilities | 430.92M | 441.83M | 454.56M | 449.20M | 442.01M |
|
|
|||||
| Common Stock & APIC | 692.58M | 689.89M | 687.18M | 560.77M | 559.28M |
| Retained Earnings | -709.78M | -692.07M | -681.82M | -657.64M | -671.47M |
| Treasury Stock & Other | -4.59M | -4.62M | -4.61M | -4.59M | -4.61M |
| Total Common Equity | -21.79M | -6.80M | 752.00K | -101.46M | -116.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.79M | -6.80M | 752.00K | -101.46M | -116.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.79M | -6.80M | 752.00K | -101.46M | -116.80M |
|
|
|||||